Immediate Impact
59 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Giulia Negrini being referenced
Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib
2018
Comparative analysis of current guidelines for the treatment of hepatocellular carcinoma
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Giulia Negrini | 192 | 174 | 122 | 140 | 13 | 433 | |
| Jonathan Israel | 207 | 191 | 77 | 48 | 12 | 456 | |
| M. Guidi | 289 | 304 | 96 | 52 | 15 | 507 | |
| J‐F Fléjou | 94 | 97 | 264 | 50 | 15 | 423 | |
| Eiichiro Yumoto | 102 | 121 | 166 | 34 | 13 | 446 | |
| Chong Kun Im | 121 | 129 | 132 | 103 | 10 | 495 | |
| J D Harrison | 112 | 110 | 250 | 39 | 17 | 465 | |
| Stephen B. Hicks | 291 | 83 | 83 | 29 | 12 | 456 | |
| George Philips | 190 | 213 | 142 | 20 | 12 | 455 | |
| Mohammed Karajeh | 249 | 229 | 133 | 47 | 11 | 437 | |
| R. Wirsching | 63 | 131 | 248 | 41 | 18 | 386 |
All Works
Loading papers...